6,832 press releases indexed under healthcare.
PALO ALTO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences:
AUSTIN, Texas, September 01, 2026--Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that management will participate in the following upcoming investor conferences:
Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a Further Reduction Paxalisib Was Well Tolerated as Monotherapy and in Combination with Checkpoint Inhibition Kazia is Preparing to...
Monthlong campaign in September aims to elevate awareness of hand health, encourage early detection of Dupuytren's contracture, and connect patients with appropriate care DUBLIN, Sept. 1, 2026 /PRNewswire/ -- Keenova Therapeutics plc today announced plans for the 2nd Annual National Hand...
BEDFORD, Mass. & CAMBRIDGE, Mass., September 01, 2026--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, and Biogen Inc.
Free 2-day online event brings together leading experts to unite functional and longevity medicine with cutting-edge science and clinical tools
OSLO, Norway & BOSTON, September 01, 2026--Calluna Pharma Announces Participation in Upcoming Conferences to highlight Phase 2 AURORA study of CAL101 in IPF ahead of planned Q1 2027 readout
(PR-inside.com) Leading physicians, scientists, regulatory experts, and healthcare innovators will convene October 23-25 at Fort Lauderdale's Pier Sixty-Six Resort + Marina for three days of regenerative medicine education, hands-on clinical training, and interdisciplinary collaboration FORT LAUDERDALE, FL / ACCESS Newswire / September 1, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO ScientifiX" or the "Company") today announced the multidisciplinary faculty and guest speaker lineup for the inaugural ZEO Xperience, a three-day immersive regenerative medicine event for healthcare professionals taking place October 23-25, 2026, at Pier Sixty-Six Resort + Marina in Fort Lauderdale, Florida. Bringing together physicians, scientists, regulatory professionals, clinical educators, and healthcare
(PR-inside.com) Regulatory Executive Brings More Than 15 Years of FDA, Medical Device, SaMD, and Digital Health Experience to Support AIML's Medical Device Strategy TORONTO, ON / ACCESS Newswire / September 1, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company advancing artificial intelligence and neural-network-based technologies for digital health, is pleased to announce that its wholly owned subsidiary, NeuralCloud Solutions Inc. ("NeuralCloud"), has appointed Dr. Mehmet A. Kosoglu, Ph.D., as Head of Regulatory. Dr. Kosoglu is a former U.S. Food and Drug Administration ("FDA") lead reviewer and scientist with more than 15 years of experience spanning medical device development, biotechnology, ..
(PR-inside.com) The Best Online PRP Course is the AACM PRP & PRF Certification Program SEATTLE, WA / ACCESS Newswire / September 1, 2026 / Among the online training options available, the American Academy of Cosmetic Medicine (AACM) is the best choice for medical professionals seeking structured, self-paced education in platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) therapies for only $299, and it is accredited for 3 hours of continuing medical education credits. The course is accredited by the Accreditation Council for Continuing Medical Education (ACCME) , the Accreditation Council for Pharmacy Education (ACPE) , and the American Nurses Credentialing Center (ANCC) , and ..
(PR-inside.com) Insurance coverage for gender affirming surgeries is accepted by Dr. Sajan SEATTLE, WA / ACCESS Newswire / September 1, 2026 / For transgender and nonbinary patients considering gender affirming surgery, insurance can be an important factor when choosing a surgeon. Dr. Javad Sajan of Allure Esthetic Plastic Surgery accepts private insurance for transgender and gender affirming surgeries and is in-network with most private insurance carriers. His practice offers a range of gender affirming procedures, including FTM top surgery , MTF breast augmentation , body contouring , tracheal shave procedures , and other surgical options based on each patient's goals. Insurance coverage for ..
(PR-inside.com) Peru becomes the newest addition to Cellgenic's Latin American commercial network - one of three coordinated market initiatives across the region, subject to applicable local regulatory requirements. MIAMI, FL / ACCESS Newswire / September 1, 2026 / Regenerative Medical Technology Group, Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, today announced the commencement of Cellgenic commercial activity in Peru through the establishment of local commercial arrangements, including exclusive representation arrangements in permitted channels. The Peru announcement extends Cellgenic's Latin American commercial network, which the Company has been building through market ..